← FDA DRUG APPROVALS
FDA ANDA · ANDA076645
LACTULOSE SOLUTION
lactulose solution usp, 10 g/15 ml
Sponsor: BAJAJ
APPLICATION
ANDA076645
TYPE
ANDA
ORIGINAL APPROVAL
2003-07-28
LATEST ACTION
2024-02-20
ROUTE
ORAL, RECTAL, ORAL, RECTAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
LACTULOSEPrescription
LACTULOSE 10GM/15ML · SOLUTION · ORAL, RECTAL
Approval history
2024-02-20Labeling · Supplement 7 · standardAP
2003-07-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.